InvestorsHub Logo
Followers 54
Posts 1239
Boards Moderated 0
Alias Born 10/09/2013

Re: Shell Man post# 30446

Monday, 07/13/2020 12:04:56 PM

Monday, July 13, 2020 12:04:56 PM

Post# of 40933
Filing an application doesn't grant them a patent, and even if there is some priority program, it won't happen overnight, if at all. Anyone can file an application, but because one of the three required criteria for being granted a patent, the invention must be novel(never before publicly proclaimed or marketed), nonobvious, and useful; is already widely available, so cannot be met...one of several existing copper embedded mask /// and is also in the news here

Besides, it looks like someone sorta beat them to it, in a thoroughly scripted application that goes WAYYYYYY beyond lacing a few copper and silver threads into a fabric so the wearer can help E.T. phone home without getting zapped by EMF radiation. And has already been granted up to date patent status for well over 2 years now. seems to belong to this company /// Link to patent number 9,901,128 for anti-microbial fabric that specifically includes face masks

But we can still give them an E for effort. And, assuming they are actually serious about this, they will most likely have to amend their application claims accordingly to actually get the patent, and won't be able to imply Covid-19 safety or market it as anti-microbial without risk of infringement lawsuit, but maybe they can still capitalize on the radiation protection feature with an infomercial.

Because I know cell phone radiation is pretty much right behind Covid concerns for most american consumers and shareholders alike in today's market sector. Especially since the cancer concerns revolve around tumors in the ear and brain, and the mask only protects the chin, but doesn't actually protect the ear, which is what everyone presses their cell phone up against.mayo clinic on cell phone safety /// FDA on cell phone radiation

Here are some Key excerpts from Lidco product's patent itself...

Antimicrobial apparel and fabric and coverings

Abstract

An apparel or material which may be placed anywhere or worn about the neck or other parts of the body of a human. The apparel/material has a structure that, when repositioned from about the wearer, will retain a position about a mouth and nose of the human, as by elasticity or taughtness of a wrapping about the face. The apparel is sufficiently porous as to allow a human to breath comfortably through the fabric when placed over the mouth and nose of the human. The fabric has as a coating is created with on at least the outer surface and through at least 25% of the thickness of the fabric a moisture-sensitive antimicrobial composition, wherein the antimicrobial moisture-sensitive composition comprises an antimicrobially active compound and a carrier, the carrier by hydrophilic and able to absorb sufficient moisture from exhaled breath from the human as to maintain a wet surface on the carrier to which viral particles will adhere more strongly than to a dry surface of the same carrier.



BACKGROUND OF THE INVENTION

Field of Invention

The present invention relates to drapable, wrappable or donnable In particular, the invention relates to articles for controlling the spread of pathogens and infectious diseases.

Background of the Art

In recent years, the prevalence of nosocomial infections has had serious implications for both patients and healthcare workers and the severity of airborne diseases brought into medical care facilities (including clinics, hospitals and long-term care homes) has reached a level of concern for health care workers. Such significant airborne diseases include at least SARS, H1N1 virus, and mutations in seasonal viruses. Nosocomial infections are those that originate, persist or occur in a hospital, long-term care facility, or other health care setting, and are sometimes referred to as "hospital associated infections" or HAI. In general nosocomial infections are more serious and dangerous than external, community-acquired infections because the pathogens in hospitals are more virulent and tend to be more resistant to typical antibiotics. These HAIs are usually related to a procedure or treatment used to diagnose or treat the patient's illness or injury and may be spread by indirect, inadvertent contact. Published U.S. Patent Application Document 2007/0044801 and Published U.S. Patent Application Document 2007/0141126 and U.S. Pat. No. 4,856,509 disclose face masks containing antimicrobial ingredients that are used as a first barrier against inhalation of such diseases, usually viruses. Bacterial infections are also becoming significant issues, with Methicyllin Resistant Strep A (MRSA) becoming a major health issue, although this is usually spread by contact rather than inhalation.



Hospitals and other healthcare facilities have developed extensive infection control programs to prevent nosocomial infections. Even though hospital infection control programs and a more conscientious effort on the part of healthcare workers to take proper precautions when caring for patients can prevent some of these infections, a significant number of infections still occur. Therefore, the current procedures are not sufficient. Despite enforcement of precautionary measures (e.g. washing hands, wearing gloves, face mask and cover gowns), contact transfer is still a fundamental cause of HAIs. That is, individuals who contact pathogen-contaminated surface such as table tops, bed rails, hands, clothing and/or medical instruments, can still transfer the pathogens from one surface to another immediately or within a short time after initial contact. To improve this situation, a standard device or article can be enhanced for infection control by addition of actives that can kill pathogens when they come in contact with the article or can bind the pathogen such that dispersal is not possible. One problem with masks is that they tend to concentrate microbes on the surface of the mask, and even where antimicrobial activity is provided with the mask, that activity tends to be internal and slow acting, and diminishes over time, allowing microbial buildup on the mask surface. Therefore when the mask is contacted, even for removal, the user can pick up concentrated microbes on their hands and spread them to others, other surfaces and to themselves.



The term "biocides" is a general term describing a chemical agent, such as a pesticide, usually broad spectrum, which inactivates living microorganisms. Because biocides range in germicidal activity, other terms may be more specific, including "-static," referring to agents that inhibit growth (e.g., bacteriostatic, fungistatic, or sporistatic) and "-cidal," referring to agents that kill the target organism (e.g., bactericidal, fungicidal, sporicidal, or virucidal). Biocides have multiple targets and modes of action, which for instance, may include physical disruption and permanent damage to the outer cell membrane of a bacterial microbe. Some example of useful biocide chemistries include biguanides (e.g.: chlorohexidine, alexidine, polyhexamethylene biguanide, and relevant salts thereof), halogen-releasing agents (e.g.: iodine, iodophors, sodium hypochlorite, N-halamine, etc.), stabilized oxidants such as chlorine dioxide, stabilized peroxide (e.g., urea peroxide, mannitol peroxide) metal-containing species and oxides thereof (e.g.: silver, copper, selenium, etc. either in particle form or incorporated into a support matrix such as a zeolite or polymer), sulfides (e.g., sodium metabisulfite), bis-phenols (e.g., triclosan, hexachlorophene, etc), quaternary ammonium compounds (e.g., benzalkonium chloride, cetrimide, cetylpyridium chloride, quaternized cellulose and other quaternized polymers, etc.), various "naturally occurring" agents (e.g., polyphenols from green or black tea extract, citric acid, chitosan, anatase TiO.sub.2, tourmaline, bamboo extract, neem oil, etc.), hydrotropes (e.g., strong emulsifiers) and chaotropic agents (e.g., alkyl polyglycosides) and synergistic combinations thereof. Depending on substrate chemistry (polyolefin vs. cellulosic-based materials) and the method of incorporation into the product (topical vs. grafting), many of the above chemistries could be used alone or in concert to achieve the final claimed product properties of interest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNOS News